Toxina botulinica en parálisis cerebral infantil: Resultados en 27 sujetos a lo largo de un año

Revista de Neurologia

Volumn 25, Issue 140, 1997, Pages 531-535

  Sanchez Carpintero R ^a,b   Narbona, J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Botiilinuma toxin; Cerebral palsy; Spasticity; Treatment

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN;

ADOLESCENT; ARTICLE; CEREBRAL PALSY; CHILD; FOLLOW UP; HUMAN; MULTIMODALITY CANCER THERAPY; PHYSIOTHERAPY; PRESCHOOL CHILD; SPASTICITY; TREATMENT OUTCOME; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; SCHOOL CHILD;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MUSCLE SPASTICITY; PHYSICAL THERAPY MODALITIES; TREATMENT OUTCOME;

EID: 0031111773     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Young RR, Delwada PJ. Drug therapy: spasticity (first and second of two parts). N Eng J Med 1981; 30: 96-99 and 304: 28-33.
2. Peacock WJ, Staudt LA. Functional outcomes following selective posterior rhizotomy in children with Cerebral Palsy. J Neurosurg 1991; 74: 340-385.
3. Abbot R. Complications with selective posterior rhizotomy. Pediatr Neurosurg 1992; 18:43-47.
4. Oppenheim WL. Selective posterior rhizotomy for spastic cerebral palsy: a review. Clin Orthop 1990; 256: 20-29.
5. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265: 1418-22.
6. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80-99.
7. Brin MF. Treatment of spasticity using local injections of botulinum toxin. The Mount Sinai Medical Center demonstrations skills workshop series. Enero 1995.
8. Carpenter EB, Seitz DG. Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neural 1980; 22: 497501.
9. Tardieu G, Tardieu C, Hariga J, Gagnard L. Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the descerebrated cat. Dev Med Child Neurol 1968; 10:555-68.
10. 10. Koman LA, Mooney JF, Smith B, et al. Management of cerebral palsy with botulinum A toxin: preliminary investigations. J Pediatr Orthop 1993; 13:489-495.
11. Williams PE, Goldsprink G. Longitudinal growth of striated muscle fibers. J Cell Science 1971; 9: 751-63.
12. Tabary JC, Tabary C, Tardieu G, et al. Phisiological and structural changes in the cat!4s soleus muscle due to inmovilization at different lengths by plaster casts. J Phisiol 1972; 224: 231 -44.
13. Tardieu G, Tardieu C, Tabary JC, Huet de la Tour E. Comparison of the sarcomere number adaptation in young and adult animals. J Phisilogie 1977; 73: 1045-55.
14. Holly RG, Barnet JG, Ashmore CR, et al. Stretch-induced growth in chicken wing muscles: A new model of stretch hypertrophy. Am J Phisiology 1980; 238: c62-c71.
15. Scott AB. Botulinum toxin injection into extra-ocular muscles as an alternative to estrabismus surgery. Ophtalmol 1980; 87: 1044-1049.
16. Jankovic J, Brim MF. Terapeutic uses of botulinum toxin. N Eng J Med 1991:324: 1186-94.
17. Roman LA, Mooney JF, Smith B, et al. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994; 14: 299-303.
18. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386-396.
19. Cosgrove AP, Graham HK. Development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1994; 36: 379-385.
20. Calderón-González R, Calderön-Sepulveda R, Rincón-Reyes M, et al. Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994; 10:284-288.
21. Denislic M, Meh D. Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics 1995; 26: 249-52.
22. Lespargot A, Marion MH, Klap P. La toxine botulique a-t-elle une place dans le traitement de l'IMC? Motricité cérébrale 1994; 15: 45-55.